Abstract
Huang K-W, Lee P-C, Chao Y, et al. Durable objective response to sorafenib and role of sequential treatment in unresectable hepatocellular carcinoma. Ther Adv Med Oncol 2022; 14: 1–14. DOI: 10.1177/17588359221099401
In the above paper, the word ‘Taiwan’ was inadvertently left-out in the authors’ affiliations, which have now been corrected in the online version of the article.